INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Rockefeller Capital Management L.P.'s Holding History (CIK: 0001739439)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 1,037,763 Value ($000) $19,240 Avg Close — Range —
Q2 2023
Shares 777,402 Value ($000) $8,598 Avg Close — Range —
Q1 2023
Shares 735,488 Value ($000) $10 Avg Close — Range —
Q4 2022
Shares 565,185 Value ($000) $7 Avg Close — Range —
Q3 2022
Shares 536,764 Value ($000) $7,487 Avg Close — Range —
Q2 2022
Shares 519,722 Value ($000) $7,177 Avg Close — Range —
Q1 2022
Shares 489,352 Value ($000) $7,961 Avg Close — Range —
Q4 2021
Shares 388,350 Value ($000) $6,326 Avg Close — Range —
Q3 2021
Shares 337,141 Value ($000) $5,006 Avg Close — Range —
Q2 2021
Shares 178,488 Value ($000) $3,564 Avg Close — Range —
Q1 2021
Shares 200 Value ($000) $4 Avg Close — Range —
Q4 2020
Shares 200 Value ($000) $4 Avg Close — Range —
Q3 2020
Shares 200 Value ($000) $8 Avg Close — Range —
Q2 2020
Shares 200 Value ($000) $10 Avg Close — Range —
Q1 2020
Shares 200 Value ($000) $13 Avg Close — Range —